Eugia Pharma`s Generic Sugammadex Receives Approval in the U.S.
Sandoz B2B`s Generic Sugammadex Receives Approval in the U.S.
Zydus Pharmaceuticals` Generic Sugammadex Receives Approval in the U.S.
Piramal Critical`s sugammadex Receives Approval in Europe
AOP Orphan`s Sugammadex Approved In Europe
Extrovis` Sugammadex Receives Approval in Europe
Mylan's Generic Sugammadex Sodium Receives Approval in the U.S.
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. District Court for the District of New Jersey ruled in favor of the company and found that Merck correctly calculated the Patent Term Extension period for the primary patent related to BRIDION® (sugammadex). Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
Aspiro's Generic Sugammadex Sodium Receives Receives Approval in the U.S.